Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial
Publication in refereed journal


Times Cited
Web of Science25WOS source URL (as at 10/12/2022) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListAbou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Park JW, Blanc JF, Bolondi L, Klumpen HJ, Chan SL, Dadduzio V, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK
Journal nameJournal of Clinical Oncology
Title of PublicationJOURNAL OF CLINICAL ONCOLOGY
Year2018
Month2
Day1
Volume Number36
Issue Number4
PublisherAMER SOC CLINICAL ONCOLOGY
ISSN0732-183X
eISSN1527-7755
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology;Oncology

Last updated on 2022-11-12 at 01:28